The oncometabolite D-2-hydroxyglutarate promotes DNA hypermethylation at lineage-specific enhancers controlling microglial activation in IDHmut gliomas
Tumor-associated macrophages and microglia in IDH-mutant gliomas exhibit DNA hypermethylation at distal enhancers, impairing transcription factor binding and reducing inflammatory and glycolytic metabolism programs. D-2-hydroxyglutarate (D-2HG) exposure inhibits TET-mediated demethylation, altering microglial responses and enhancing oxidative phosphorylation. Depletion of D-2HG in a glioma patient restored microglial reactivity, suggesting oncometabolites disrupt immune cell function in the tumor microenvironment.
Style rédactionnelFactuel
Complete fact; the text is a scientific abstract presenting research findings.

